Accessibility Menu
Steris logo

Steris(NYSE) STE

Market Cap$22.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+15,530%
5 Year+12%
1 Year-4%
1 Month+2%
Premium Feature
Moneyball Superscore
71/100
$229.37
-1.41%
-3.27Today
After hours$229.68+$0.31 (+0.14%)
Steris last closing stock price
MetricPriceDate
Last closeUSD 232.642026-08-31
Steris stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.2%USD 237.872026-08-24
1 month+1.86%USD 228.402026-07-31
3 month+11.24%USD 209.142026-06-02
Year to date-7.73%USD 252.132025-12-31
1 year-4.06%USD 242.482025-08-29
3 year+3.83%USD 224.072023-09-01
5 year+12.33%USD 207.102021-09-01
Since inception+15,529.73%USD 1.491992-06-01

Steris Financials at a Glance

Market Cap

$22.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.04B

Net Income (TTM)

$805.10M

EPS (TTM)

$8.18

P/E Ratio

28.44

Dividend

$2.52

Beta (Volatility)

0.73 (Low)

Price

$229.37

Volume

558,504.863

Open

$233.88

Previous Close

$229.65

Daily Range

$228.96 - $234.50

52-Week Range

$195.14 - $269.44

Estimated Earnings Date

Nov 4, 2026

STE: Motley Fool Moneyball Superscore

71

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Steris

STERIS plc helps hospitals keep their tools clean. It makes machines that kill germs on medical gear. The company cleans tools for doctors and drug makers.

Essential Tools for Patient Care

  • Healthcare: Equipment and services for operating rooms and sterile processing; reported $1,048.3 million in revenue for the three months ended June 30, 2026.
  • Applied Sterilization Technologies: Contract sterilization and lab testing for manufacturers; contributed $297.6 million in revenue for the three months ended June 30, 2026.
  • Life Sciences: Specialized equipment and chemicals for drug production; generated $146.7 million in revenue for the three months ended June 30, 2026.

Growth and Global Expansion

  • Completed three tuck-in acquisitions for $17.3 million during the first quarter of fiscal 2027 to expand Healthcare services.
  • Announced a plan in Aug. 2026 to consolidate manufacturing and distribution for formulated chemistries into a new North Carolina facility.
  • Executed a restructuring plan that eliminated roughly 300 positions by March 31, 2026, to improve efficiency.

Innovation and Global Networks

STERIS focuses on research and development to enhance sterile processing technologies and gastrointestinal endoscopy accessories. The company leverages a global network to provide essential maintenance, repair, and microbial reduction services to medical facilities.

The Financial Picture

  • Total revenues rose 7.3% to $1,492.7 million for the three months ended June 30, 2026.
  • Gross profit reached 45.8% for the three months ended June 30, 2026, up from 45.1% in the prior year period.
  • Income from operations was $285.8 million for the three months ended June 30, 2026.
  • Market capitalization stood at $20.6 billion during the first quarter of fiscal 2027.
  • Cash flows from operations were $367.1 million for the three months ended June 30, 2026.

Bottom Line

STERIS has evolved into a diversified provider of cleaning services and medical equipment. Its focus on recurring revenue from services and supplies supports steady business performance.

AI Generated • Aug 8, 2026

Industry

Healthcare Equipment and Supplies

Employees

17,937

CEO

Daniel A. Carestio

Headquarters

Mentor, OH 44060, US

STE Financials

Key Financial Metrics (TTM)

Gross Margin

44.43%

Operating Margin

18.91%

Net Income Margin

13.33%

Return on Equity

11.27%

Return on Capital

11.88%

Return on Assets

7.50%

Earnings Yield

3.52%

Dividend Yield

1.08%

Payout Ratio

30.68%

Stock Overview

Market Cap

$22.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

97.50M

Volume

558.50K

Avg. Volume

767.27K

Financials (TTM)

Gross Profit

$2.68B

Operating Income

$1.14B

EBITDA

$1.81B

Operating Cash Flow

$1.29B

Capital Expenditure

-$362.90M

Free Cash Flow

$925.60M

Cash & ST Invst.

$482.30M

Total Debt

$2.04B

Steris Performance Analysis

Steris annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 4,536,266,000-1.1%
20242024-03-31USD 5,138,701,00013.3%
20252025-03-31USD 5,459,515,0006.2%
20262026-03-31USD 5,935,900,0008.7%
Steris sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-305.0%
Q32025-12-312.5%
Q42026-03-316.2%
Q12026-06-30-6.0%
Steris annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD 1.07-57.0%
20242024-03-31USD 3.81256.5%
20252025-03-31USD 6.3566.7%
20262026-03-31USD 7.9324.9%
Steris sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-308.4%
Q32025-12-311.0%
Q42026-03-3114.3%
Q12026-06-30-8.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$1.49B

+7.3%

Gross Profit

$684.20M

+8.9%

Gross Margin

45.84%

N/A

Market Cap

$22.68BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.26M

N/A

Employees

17,937

N/A

Net Income

$200.10M

+12.8%

EBITDA

$349.40M

-4.8%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$482.30M

+72.4%

Total Debt

$2.04B

-1.2%

Accounts Receivable

$1.01B

+7.0%

Inventory

$712.10M

+11.1%

Long Term Debt

$1.77B

-13.2%

Short Term Debt

$279.00M

+690.4%

Return on Assets

7.50%

N/A

Return on Invested Capital

12.08%

N/A

Free Cash Flow

$279.60M

-14.3%

Operating Cash Flow

$367.10M

-12.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WSTWest Pharmaceutical Services, Inc.
$338.65-0.72%
PHGKoninklijke Philips N.V.
$26.59+0.08%
DGXQuest Diagnostics Incorporated
$236.22-1.70%
ZBHZimmer Biomet Holdings, Inc.
$99.40-0.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$14.06+0.06%
NVDANvidia
$217.44-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.33-0.06%
INTCIntel
$88.97-0.01%

Questions About STE

What is the current price of Steris?

Steris is trading at $229.65 per share.

What is the 52-week range for Steris?

Over the past 52 weeks, Steris has traded between $195.14 and $269.44.

How much debt does Steris have?

As of the most recent reporting period, Steris reported total debt of $2.04B.

How much cash does Steris have on hand?

Steris reported $482.30M in cash and cash equivalents in its most recent financial results.

What is Steris’s dividend yield?

Steris currently has a dividend yield of 1.08%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.